Press Release Trevi Therapeutics to Participate in Upcoming August Conferences Trevi Therapeutics, Inc. · Jul 28
Press Release Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer Kazia Therapeutics Ltd · Jul 28
Press Release ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform ZenaTech Inc. · Jul 28
Press Release Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O’Grady as Chief Executive Officer to Lead Strategic Growth Nasus Pharma, Ltd. · Jul 28
Press Release Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD) Dyne Therapeutics, Inc. · Jul 28
Press Release Riot Announces Second Quarter 2026 Earnings Conference Call Riot Platforms, Inc. · Jul 28
Press Release Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference Plus Therapeutics Inc. · Jul 28
Press Release China Literature to Report First Half 2026 Financial Results on August 11, 2026 China Literature · Jul 28
Press Release Department of Culture and Tourism – Abu Dhabi Announces 11 December 2026 Opening of Guggenheim Abu Dhabi Department of Culture and Tourism - Abu Dhabi · Jul 28
Press Release VR Confirms New IP and Conductivity Anomalies on its Bonita Property Porphyry Copper-Gold Project in Nevada VR Resources Ltd. · Jul 28
Press Release Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus Atea Pharmaceuticals, Inc. · Jul 28
Press Release Midera Food Processing Schedules Second Quarter 2026 Earnings Release and Conference Call Midera Food Processing, Inc. · Jul 28